Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist
Xiangqian Li, Xiaowei Li, Fang Liu, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 10581-10605
Closed Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih, Islam M. Abdel-Rahman, Nawal El‐Koussi, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 966-1010
Open Access | Times Cited: 2
Combining cisplatin and a STING agonist into one molecule for metalloimmunotherapy of cancer
Shuren Zhang, Dongfan Song, Wenhao Yu, et al.
National Science Review (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26
A review on pyrimidine-based pharmacophore as a template for the development of hybrid drugs with anticancer potential
Shivam Sharma, M. Arockia Babu, Roshan Kumar, et al.
Molecular Diversity (2025)
Closed Access | Times Cited: 1
Recent advances in the syntheses and reactions of biologically promising β-lactam derivatives
Rajarshi Sarkar, Dripta De Joarder, Chhanda Mukhopadhyay
Tetrahedron (2025) Vol. 177, pp. 134565-134565
Closed Access | Times Cited: 1
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
Sandra Codony, Caterina Pont, Christian Griñán‐Ferré, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4909-4925
Open Access | Times Cited: 38
Current trends in development of HDAC-based chemotherapeutics
Narges Cheshmazar, Maryam Hamzeh‐Mivehroud, Hojjatollah Nozad Charoudeh, et al.
Life Sciences (2022) Vol. 308, pp. 120946-120946
Closed Access | Times Cited: 36
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 33
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 22
New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies
Wael A.A. Fadaly, Taha H. Zidan, Nesma M. Kahk, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 22
Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer’s Disease
Галина Ф. Махаева, N. V. Kovaleva, Елена В. Рудакова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2285-2285
Open Access | Times Cited: 21
Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
Amgad Gerges, Una Canning
ChemMedChem (2024) Vol. 19, Iss. 9
Open Access | Times Cited: 8
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4916-4935
Closed Access | Times Cited: 8
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 7
Palladium-catalyzed asymmetric [4+2] annulation of vinyl benzoxazinanones with pyrazolone 4,5-diones to access spirobenzoxazine frameworks
Ben‐Hong Chen, Shuai‐Jiang Liu, Qian Zhao, et al.
Chemical Communications (2023) Vol. 59, Iss. 9, pp. 1233-1236
Closed Access | Times Cited: 16
Advances in the development of phosphodiesterase 7 inhibitors
Jiaxi Huang, Bolin Zhu, Jiangping Xu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115194-115194
Closed Access | Times Cited: 15
Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease
Juan‐yue Long, Fengxue Qin, Jinchong Luo, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107026-107026
Closed Access | Times Cited: 14
Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities
Wei-Biao Zang, Huiling Wei, Weiwei Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116070-116070
Closed Access | Times Cited: 14
Recent advances in multitarget-directed ligands via in silico drug discovery
Maddeboina Krishnaiah, Bharath Yada, Shikha Kumari, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103904-103904
Closed Access | Times Cited: 6
Recent development of BTK-based dual inhibitors in the treatment of cancers
Fansheng Ran, Yun Liu, Zhongyuan Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114232-114232
Closed Access | Times Cited: 22
Favipiravir vs. Deferiprone: Tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2
Nikolay Tzvetkov, Martina I. Peeva, Maya G. Georgieva, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100176-100176
Open Access | Times Cited: 4
Deep simulated annealing for the discovery of novel dental anesthetics with local anesthesia and anti-inflammatory properties
Yi-hang Hao, Haofan Wang, Xianggen Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3086-3109
Open Access | Times Cited: 4
Research progress of DDR1 inhibitors in the treatment of multiple human diseases
Mengying Liu, Jifa Zhang, Xiaoxue Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116291-116291
Closed Access | Times Cited: 4
Chemical synthesis and molecular docking study of new thiazole, thiophene, and thieno[2,3-d]pyrimidine derivatives as potential antiproliferative and antimicrobial agents
Ismail M. M. Othman, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
Journal of Molecular Structure (2022) Vol. 1270, pp. 133926-133926
Closed Access | Times Cited: 19
Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease
Maria V. Grishchenko, Галина Ф. Махаева, Yanina V. Burgart, et al.
ChemMedChem (2022) Vol. 17, Iss. 10
Open Access | Times Cited: 18
Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer
Xiaoyu Chen, Chengxia Shu, Wenqiang Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6729-6747
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top